{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:00:45Z","timestamp":1780560045803,"version":"3.54.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Melanoma patients\u2019 prognosis is based on the primary tumor characteristics and the tumor status of the regional lymph nodes. The advent of lymphoscintigraphy with SLN biopsy (SLNB) has shown that melanoma can drain to multiple nodal basins but the significance of multiple basins (vs. one basin) with tumor-positive sentinel lymph node(s) (+SLN) of similar tumor burden has not been shown. We examined the impact of the number of nodal basins with +SLN (+basin) in melanoma patients and its significance for patients\u2019 prognosis and survival.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study design<\/jats:title><jats:p>We identified 1,915 patients with +SLN from two randomized surgical clinical trials: Multicenter Selective Lymphadenectomy Trials I and II. Patient groups were divided based on number of +SLNs and number of +basins. Disease-free survival (DFS), distant disease-free survival (DDFS) and melanoma-specific survival (MSS) were compared with the Kaplan-Meier method and log-rank tests. Univariable and multivariable analyses were performed using Cox proportional hazard regressions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 1,915 patients, 1,501 had only one +SLN (78%) in one basin and 414 (22%) had multiple +SLNs: 340 located in one basin and 74 in multiple basins. Among patients with multiple +SLNs, those with multiple +basins have a worse DFS, DDFS and MSS than those with a single basin (p \u2264 0.0001 for all comparisons). MSS was significantly different based on AJCC stages: AJCC IIIA and IIIB (p \u2264 0.001 and 0.0287, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results suggest that the number of tumor-positive basins may be important for staging and in understanding the biology of lymph node metastases.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1416685","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T04:38:21Z","timestamp":1720413501000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Implications of tumor-positive sentinel lymph nodes in single vs multiple nodal basins in melanoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Emiliano","family":"Reyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel","family":"Lourdault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judi Anne","family":"Ramiscal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Essner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3390\/medicina59071241","article-title":"Invasive cutaneous melanoma: evaluating the prognostic significance of some parameters associated with lymph node metastases. Medicina (Kaunas)","volume":"59","author":"Vita","year":"2023"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6513-7","article-title":"Melanoma staging: American joint committee on cancer (AJCC) 8th edition and beyond","volume":"25","author":"Gershenwald","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-12804-6","article-title":"Risk stratification of sentinel node metastasis disease burden and phenotype in stage III melanoma patients","volume":"30","author":"Hussain","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jamcollsurg.2020.11.015","article-title":"Stage IIIa melanoma and impact of multiple positive lymph nodes on survival","volume":"232","author":"Woeste","year":"2021","journal-title":"J Am Coll Surg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-020-10028-0","article-title":"Sentinel node tumor burden in prediction of prognosis in melanoma patients","volume":"37","author":"Palve","year":"2020","journal-title":"Clin Exp Metastasis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/843214","article-title":"Survival rates of patients with metastatic Malignant melanoma","volume":"7","author":"Sandru","year":"2014","journal-title":"J Med Life"},{"key":"B7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3322\/canjclin.54.3.131","article-title":"An evidence-based staging system for cutaneous melanoma","volume":"54","author":"Balch","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1983.1.2.126","article-title":"A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III)","volume":"1","author":"Balch","year":"1983","journal-title":"J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia","volume":"52","author":"Balch","year":"1983","journal-title":"Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/00000658-199110000-00013","article-title":"Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic","volume":"214","author":"Morton","year":"1991","journal-title":"Ann Surg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00172","article-title":"Prognostic value of multiple draining lymph node basins in melanoma: A matched-pair analysis based on the John Wayne cancer institute experience","volume":"7","author":"Howard","year":"2017","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejca.2019.07.004","article-title":"Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden","volume":"123","author":"Satzger","year":"2019","journal-title":"Eur J Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03034","article-title":"Prognosis of patients with stage III melanoma according to American joint committee on cancer version 8: A reassessment on the basis of 3 independent stage III melanoma cohorts","volume":"38","author":"Garbe","year":"2020","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2020.02.029","article-title":"Trends in completion lymph node dissection for patients with melanoma","volume":"230","author":"Bartlett","year":"2020","journal-title":"J Am Coll Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.3390\/cancers15143630","article-title":"Presence of circulating tumor cells predates imaging detection of relapse in patients with stage III melanoma","volume":"15","author":"Lucci","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.3390\/ijms22094561","article-title":"Prognostic and predictive biomarkers in stage III melanoma: current insights and clinical implications","volume":"22","author":"Tonella","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9098(199712)66:4<267::AID-JSO9>3.3.CO;2-Y","article-title":"Sentinel lymphadenectomy for patients with clinical stage I melanoma","volume":"66","author":"Morton","year":"1997","journal-title":"J Surg Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1416685\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T04:38:24Z","timestamp":1720413504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1416685\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":22,"alternative-id":["10.3389\/fonc.2024.1416685"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1416685","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,8]]},"article-number":"1416685"}}